Home › Research › Down syndrome and Alzheimer's
The Amyloid Plaque Proteomes of Alzheimer’s Disease and Mild Cognitive Impairment
Leitner D, Kanshin E, Balcomb K, Askenazi M, Suazo J, Marta-Ariza M, schneider J, Ueberheide B et al.. Research Square, 2026-03-08
Topic: Genetics and APOE
Plain-language summary
Amyloid plaques contain numerous proteins in addition to amyloid beta in Alzheimer’s disease (AD). Previous localized proteomics identified plaque-associated proteins in late-onset AD, early-onset AD, rapidly progressive AD, preclinical AD, and AD in Down syndrome, although most studies had smaller cohorts and focused primarily on severe pathology. The amyloid plaque proteome in mild cognitive impairment (MCI) has not been evaluated. We evaluated plaque proteomes in MCI and AD with comparisons to neighboring non-plaque tissue and control non-plaque tissue from ROSMAP (151 cases (n = 240 samples); control (n = 62), MCI (n = 36), AD (n = 53)). Tissue was microdissected from autopsy paraffin embedded temporal cortex and evaluated by label-free quantitative proteomics. We identified differentially abundant proteins with robust differences at a false discovery rate (FDR) < 5% and fold-change > 1.5 for 135 proteins in MCI and 156 in AD plaque tissue compared to neighboring non-plaque tissue, which included proteins described previously as well as novel proteins. Gene ontology (GO) term associations included increased inflammatory response and lysosome proteins in both MCI and AD, and decreased myelin proteins particularly in AD. Of plaque proteins altered in at least one disease group, many changed in the same fold-change direction (p < 0.0001, R 2 = 0.53) and there were 100 shared proteins in MCI and AD. In non-plaque tissue, there were 277 differentially abundant proteins in MCI and 177 in AD; associated with structural constituent of chromatin in MCI and negative regulation of DNA recombination and autolysosome in AD, with decreased proteins associated with actin-myosin filament in AD. Weighted gene correlation network analysis (WGCNA) identified proteins associated with pathology and demographics. We have conducted the most extensive proteomics of microdissected plaque proteomes in both MCI and AD. Our results provide insights into MCI and AD molecular mechanisms, novel biomarkers, and potential novel therapeutic targets.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Leitner, D., Kanshin, E., Balcomb, K., Askenazi, M., Suazo, J., Marta-Ariza, M., et al. (2026). The Amyloid Plaque Proteomes of Alzheimer’s Disease and Mild Cognitive Impairment. Research Square. https://doi.org/10.21203/rs.3.rs-9012095/v1
Vancouver
Leitner D, Kanshin E, Balcomb K, Askenazi M, Suazo J, Marta-Ariza M, et al. The Amyloid Plaque Proteomes of Alzheimer’s Disease and Mild Cognitive Impairment. Research Square. 2026. doi:10.21203/rs.3.rs-9012095/v1.
BibTeX
@article{leitner2026-e4a188be,
author = {Leitner, D. and Kanshin, E. and Balcomb, K. and Askenazi, M. and Suazo, J. and Marta-Ariza, M. and schneider, J. and Ueberheide, B. and others},
title = {{The Amyloid Plaque Proteomes of Alzheimer’s Disease and Mild Cognitive Impairment}},
journal = {Research Square},
year = {2026},
doi = {10.21203/rs.3.rs-9012095/v1},
url = {https://doi.org/10.21203/rs.3.rs-9012095/v1}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- We identified differentially abundant proteins with robust differences at a false discovery rate (FDR) < 5% and fold-change > 1.5 for 135 proteins in MCI and 156 in AD plaque tissue compared to neighboring non-plaque tissue, which included proteins described previously as well as novel proteins.
- In non-plaque tissue, there were 277 differentially abundant proteins in MCI and 177 in AD; associated with structural constituent of chromatin in MCI and negative regulation of DNA recombination and autolysosome in AD, with decreased proteins associated with actin-myosin filament in AD.
- Weighted gene correlation network analysis (WGCNA) identified proteins associated with pathology and demographics.
- Our results provide insights into MCI and AD molecular mechanisms, novel biomarkers, and potential novel therapeutic targets.
Study details
- Participants240
- Evidence strengthLow
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 29 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 18 of the 62 points we could judge it on, which is 29 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (Research Square) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 2 / 4 | 240 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 18 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 18 of the 62 points we could judge it on is 29 out of 100. |
| Total | 29 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “single-nucleus”
274 studies in the library carry the topic tag “single-nucleus”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 274 tagged studies.